News und Analysen

In this podcast, Motley Fool analyst Nick Sciple and host Mary Long discuss:

Mesoblast CEO Silviu Itescu joins Motley Fool host Ricky Mulvey for a conversation about how to price medical treatments

AT&T (NYSE: T) is making waves again, climbing toward its 52-week high and locking in billion-dollar fiber deals. With rising cash flow, solid dividends, and 5G ambitions, is this legacy telecom

The 2020s did not start well for AT&T (NYSE: T) stock.

In the 2010s, the company veered from the wireless-focused business models of its competitors and invested heavily in non-core businesses such

The stock market isn't having a great year, with the S&P 500 down 0.4% at the time of this writing. Not all companies have been equally affected by tariff announcements and the possibility of a

Nearly every company that's even remotely related to the tech industry is betting that artificial intelligence (AI) will be a key driver of their business in the coming years. This is giving

It's been a tough go for Pfizer (NYSE: PFE). Shares of the pharmaceutical giant are down over 60% from their highs, a multi-year slide since pandemic-related sales peaked a few years ago. But that's

Telecom giant AT&T (NYSE: T) doubled down on its fiber internet strategy on Wednesday with a $5.75 billion deal to acquire Lumen's Mass Markets fiber business. The acquisition will come with

The stock market is anything but normal right now. Not even halfway through the year, the broader benchmark S&P 500 index fell nearly 20% from highs made in February, only to make a full recovery

Many investors love the "big mo." That's short for "big momentum." Stocks that are on a roll often keep the good times going.

Three Fool.com contributors think they've found high-flying biotech

Have you ever wondered if an established drugmaker could do better at genetics-guided research than a consumer-focused diagnostics business? Well, we could find out.

Recently, Regeneron (NASDAQ:

Most people like to buy products when prices are cheaper. That's why you'll probably see lots of car dealers, furniture stores, and retailers advertising special sales during the Memorial Day

Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities.

*Stock prices used were the afternoon prices of May 20, 2025. The video was published on May 22, 2025.

Continue reading

Broader equities have been volatile this year, but that's par for the course. The fact that the stock market will sometimes go through erratic periods is not a good reason not to invest. However

Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two leaders in this area, Eli Lilly and Novo Nordisk. However, several other

No one knows where President Trump's trade war will go next.

Despite the stock market's recovery from the April "Liberation Day" crash, there are a number of high-profile companies that remain

The roller-coaster ride of volatility continues for Super Micro Computer (NASDAQ: SMCI) stock. At one point in the last five years, the computer rack assembler for artificial intelligence (AI) data

Though there are plenty of dividend stocks on the market, they aren't all created equal. Consider that the average dividend yield for the S&P 500 (SNPINDEX: ^GSPC) is 1.3%, which is not particularly

Investing in growth stocks is a great way to grow your portfolio in the long run. But it can be difficult to predict which ones will take off in value and which one's won't. And that's why it might

Dividend stocks can be a smart way to generate steady income, especially in uncertain markets. However, not all dividend payers are created equal. A recent study from Ned Davis Research and Hartford

Despite making significant clinical progress, CRISPR Therapeutics (NASDAQ: CRSP) has been struggling financially in the past three years. The company's shares are down by 24% over this period, while

Following a visit to Saudi Arabia last week, President Donald Trump announced that the kingdom has pledged to invest $600 billion in deals with U.S. companies. The agreement includes $142 billion in

Make money without even trying: That's what passive income is all about. But good investment alternatives are required to make this "easy" money.

Three Motley Fool contributors believe they have

A major C-suite change at a potential competitor was a key factor behind the rise of Viking Therapeutics (NASDAQ: VKTX) stock on Friday, which closed the trading session 3% higher. That figure was

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.